Deep learning and cancer biomarkers: recognising lead-time bias

Lancet. 2021 Jan 16;397(10270):194. doi: 10.1016/S0140-6736(20)32402-8.

Authors

Michael Bretthauer¹, Magnus Løberg², Øyvind Holme², Hans-Olov Adami², Mette Kalager²

Affiliations

¹ Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo 0318, Norway. Electronic address: michael.bretthauer@medisin.uio.no.
² Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo 0318, Norway.

PMID: 33453776
DOI: 10.1016/S0140-6736(20)32402-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Algorithms
Biomarkers, Tumor
Colorectal Neoplasms*
Deep Learning*
Humans
Neural Networks, Computer

Substances

Biomarkers, Tumor